Marcus is 9 years old. He hates reading, complains of headaches after school, and his teacher suspects ADHD. His pediatrician orders a comprehensive eye exam. His distance vision is 20/20. But when the optometrist tests his convergence — his eyes’ ability to turn inward together while focusing on something close — the near point of convergence is 8 inches out instead of the normal 2–3 inches. His eyes can’t sustain the inward turn needed for reading. The diagnosis: convergence insufficiency. The recommended treatment: vision therapy.
This scenario plays out thousands of times a year. And it’s one of the situations where vision therapy has genuinely strong research support. Understanding what it costs — and what the evidence actually says — matters before signing any $3,000 treatment contract.
What Vision Therapy Is
Vision therapy is a structured, supervised program of eye exercises and activities designed to improve visual skills that glasses or contacts don’t address. Think of it as physical therapy, but for the visual system. Sessions happen at the optometrist’s office — typically with a trained vision therapist — and are supplemented by at-home exercises.
The skills targeted depend on diagnosis: convergence, divergence, tracking (saccadic eye movements), sustained focus (accommodation), binocular coordination, and depth perception processing.
| Program Type | Per Session Cost | Total Sessions | Estimated Total Cost |
|---|---|---|---|
| Initial evaluation | One-time | — | $200–$400 |
| Short program (12–20 sessions) | $100–$200 | 12–20 | $1,200–$4,000 |
| Standard program (24–36 sessions) | $100–$200 | 24–36 | $2,400–$7,200 |
| Most real-world programs (negotiated) | — | — | $1,500–$5,000 |
| Home therapy kit (supplemental) | — | — | $100–$500 |
Sessions are typically weekly or twice-weekly, 45–60 minutes each. A standard program spans 4–6 months.
Where the Evidence Is Strong: Convergence Insufficiency
The Convergence Insufficiency Treatment Trial (CITT) is the gold-standard study on this question. Published in the Archives of Ophthalmology in 2008 and followed by additional studies through 2009, it was funded by the National Eye Institute — not by vision therapy industry groups.
The CITT randomized 221 children ages 9–17 with diagnosed convergence insufficiency into four groups: office-based vision therapy, home-based pencil push-ups, home-based computer therapy, and a placebo control. Results were unambiguous: office-based vision therapy was significantly superior to all other interventions. About 73% of the office VT group achieved successful or improved outcomes, compared to 43% in the home-based pencil push-up group.
That’s the honest answer for convergence insufficiency: in-office vision therapy works, home exercises are significantly less effective, and the research is solid.
Strong evidence supports vision therapy for:
- Convergence insufficiency (CITT, Archives of Ophthalmology 2008–2009)
- Post-surgical strabismus rehabilitation
- Amblyopia as an adjunct treatment in some cases
- Acquired brain injury / traumatic brain injury visual rehabilitation
Weak or no evidence for:
- Dyslexia and reading disabilities (AAO position statement: “No evidence supports VT for reading disabilities”)
- ADHD attention difficulties
- General academic underperformance
- Autism spectrum visual processing claims
The AAO and AOA have genuinely different positions on vision therapy’s scope. This isn’t settled — be an informed consumer.
The Dyslexia Problem
Many vision therapy providers market their services for children with reading difficulties. This needs direct clarification.
Dyslexia is a language-based learning disorder rooted in phonological processing — the brain’s ability to connect letters and letter sequences to sounds. It’s not a vision disorder. An otherwise normal eye exam in a child with dyslexia doesn’t indicate a visual cause for their reading difficulty.
The AAO’s official Complementary Therapy Task Force policy statement is explicit: there is no scientific evidence that vision therapy treats dyslexia, ADHD, or other learning disabilities. The appropriate intervention for dyslexia is structured literacy instruction (Orton-Gillingham, Wilson Reading System). Pursuing vision therapy instead delays effective treatment.
If a child has both a diagnosed binocular vision problem and reading difficulties, addressing the binocular vision issue is appropriate — but it won’t treat the underlying dyslexia.
Insurance Coverage: Medical, Not Vision
Vision insurance plans (VSP, EyeMed, Cigna Vision) don’t cover vision therapy. When coverage exists, it comes through medical insurance — because convergence insufficiency and strabismus are medical diagnoses.
To pursue coverage:
- Obtain formal diagnosis documentation with appropriate ICD-10 codes (H51.11 for CI)
- Get pre-authorization from your medical insurer before starting treatment
- Ensure your provider documents medical necessity, not just the diagnosis
- Check whether your plan covers “rehabilitative services” or “occupational therapy” — VT sometimes bills under these categories
Even with good coverage, most plans apply deductibles and coinsurance. Expect $500–$1,500 out-of-pocket even with successful coverage on a standard program.
Before committing to a $3,000+ vision therapy program, consider getting a second opinion from a board-certified ophthalmologist, particularly if the recommendation is for a child with learning difficulties rather than a clearly documented binocular vision condition. The fee for a second opinion ($200–$400) is minor compared to a multi-thousand-dollar therapy program that may not address the actual underlying problem.
Finding the Right Provider
Not all optometrists who offer vision therapy have equivalent training. When evaluating providers, ask:
- What is the specific diagnosis, and what’s the published evidence base for treating it with vision therapy?
- What outcome measures will you use to track progress — and at what point do we reassess if improvement isn’t occurring?
- Is the prescribing provider certified through COVD (College of Optometrists in Vision Development)?
- Will you provide insurance documentation for medical coverage submission?
The FCOVD credential (Fellow of the College of Optometrists in Vision Development) indicates advanced training in binocular vision and visual rehabilitation. It’s a reasonable minimum bar to set when choosing a provider for structured vision therapy.
Bottom Line
Vision therapy costs $1,500–$5,000 for a standard program, with sessions at $100–$200 each. For convergence insufficiency, the evidence from the NIH-funded CITT trial is genuinely strong — in-office therapy significantly outperforms home-based exercises. For dyslexia and learning disabilities, the evidence does not support vision therapy. Medical insurance sometimes covers it for diagnosable binocular conditions; vision insurance typically doesn’t. Know the diagnosis, understand the evidence, and get a second opinion before investing several thousand dollars.
Frequently Asked Questions
Vision insurance (VSP, EyeMed, Cigna Vision) generally does not cover vision therapy. Coverage, when it exists, comes from medical insurance — because conditions like convergence insufficiency are diagnosed medical conditions, not refractive issues. Submit claims to your medical insurer with the appropriate diagnosis code (H51.11 for convergence insufficiency), and ensure your provider documents medical necessity thoroughly before starting treatment.
FCOVD stands for Fellow of the College of Optometrists in Vision Development. It's a post-doctoral credential requiring case submissions, written examinations, and a clinical examination. Not all optometrists who offer vision therapy have this designation. While it doesn't guarantee appropriate treatment for your specific condition, it indicates advanced training in binocular vision — a reasonable baseline to look for when evaluating providers.
This distinction matters enormously. If your child struggles with reading, the first evaluation should be with an educational psychologist or reading specialist to assess phonological processing — because dyslexia is a language-based condition, not a vision condition. The AAO's official position is that there's no evidence vision therapy treats dyslexia. Vision therapy is appropriate when a child has a diagnosable binocular vision problem — eyes that don't team, track, or converge correctly — not when the presenting problem is primarily reading difficulty.